These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26395074)
1. Leveraging existing data sets to generate new insights into Alzheimer's disease biology in specific patient subsets. Fowler KD; Funt JM; Artyomov MN; Zeskind B; Kolitz SE; Towfic F Sci Rep; 2015 Sep; 5():14324. PubMed ID: 26395074 [TBL] [Abstract][Full Text] [Related]
2. A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Xu PT; Li YJ; Qin XJ; Kroner C; Green-Odlum A; Xu H; Wang TY; Schmechel DE; Hulette CM; Ervin J; Hauser M; Haines J; Pericak-Vance MA; Gilbert JR Mol Cell Neurosci; 2007 Nov; 36(3):313-31. PubMed ID: 17822919 [TBL] [Abstract][Full Text] [Related]
3. Integration of transcriptomic and genomic data suggests candidate mechanisms for APOE4-mediated pathogenic action in Alzheimer's disease. Caberlotto L; Marchetti L; Lauria M; Scotti M; Parolo S Sci Rep; 2016 Sep; 6():32583. PubMed ID: 27585646 [TBL] [Abstract][Full Text] [Related]
4. RNA-Seq data mining: downregulation of NeuroD6 serves as a possible biomarker for alzheimer's disease brains. Satoh J; Yamamoto Y; Asahina N; Kitano S; Kino Y Dis Markers; 2014; 2014():123165. PubMed ID: 25548427 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848 [TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice. Lattanzio F; Carboni L; Carretta D; Rimondini R; Candeletti S; Romualdi P Neuroscience; 2014 Jan; 256():360-9. PubMed ID: 24161275 [TBL] [Abstract][Full Text] [Related]
7. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population. Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573 [TBL] [Abstract][Full Text] [Related]
8. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease. Huang Y Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952 [TBL] [Abstract][Full Text] [Related]
9. A statistical and biological approach for identifying misdiagnosis of incipient Alzheimer patients using gene expression data. Joseph S; Robbins KR; Rekaya R Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5854-7. PubMed ID: 17947171 [TBL] [Abstract][Full Text] [Related]
10. Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer's disease. Guerini FR; Agliardi C; Sironi M; Arosio B; Calabrese E; Zanzottera M; Bolognesi E; Ricci C; Costa AS; Galimberti D; Griffanti L; Bianchi A; Savazzi F; Mari D; Scarpini E; Baglio F; Nemni R; Clerici M J Alzheimers Dis; 2014; 42(3):1015-28. PubMed ID: 25024311 [TBL] [Abstract][Full Text] [Related]
11. Hidden risk genes with high-order intragenic epistasis in Alzheimer's disease. Sun J; Song F; Wang J; Han G; Bai Z; Xie B; Feng X; Jia J; Duan Y; Lei H J Alzheimers Dis; 2014; 41(4):1039-56. PubMed ID: 24762948 [TBL] [Abstract][Full Text] [Related]
12. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease. Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415 [TBL] [Abstract][Full Text] [Related]
13. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596 [TBL] [Abstract][Full Text] [Related]
14. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression. Cacabelos R Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277 [TBL] [Abstract][Full Text] [Related]